Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
Department of Radiology, Medical University of Vienna, Vienna, Austria.
J Neurointerv Surg. 2020 Apr;12(4):401-406. doi: 10.1136/neurintsurg-2019-015332. Epub 2019 Sep 26.
Gamma Knife radiosurgery (GKRS) in the treatment of arteriovenous malformations (AVMs) is still controversially discussed.
To present long-term follow-up data on patients after Gamma Knife radiosurgery for cerebral AVMs.
Overall, 516 patients received radiosurgery for cerebral AVMs between 1992 and 2018 at our department, of whom 265 received radiosurgery alone and 207 were treated with a combined endovascular-radiosurgical approach. Moreover, 45 patients were treated with a volume-staged approach. Two eras were analyzed, the pre-modern era between 1992 and 2002 and the modern era thereafter.
In GKRS-only treated patients, median time to nidus occlusion was 3.8 years. Spetzler-Ponce (SP) class was a significant predictor for time to obliteration in the whole sample. Median time to obliteration for the combined treatment group was 6.5 years. Patients in the pre-modern era had a significantly higher obliteration rate than those treated in the modern era. Overall, the calculated yearly hemorrhage risk in the observation period after first GKRS was 1.3%. Permanent post-radiosurgical complications occurred in 4.9% of cases but did not differ between the treatment groups or treatment eras. The obliteration rate was significantly lower and the hemorrhage rate was higher in volume-staged treated patients than in conventionally treated patients.
GKRS is an effective treatment option for SP class A and B cerebral AVMs. After combined endovascular-radiosurgical treatment, the outcome of selected SP class C AVMs aligns with that of SP class B lesions. Both the combined therapy and radiosurgery alone constitute sound methods for treatment of cerebral AVMs.
伽玛刀放射外科(GKRS)治疗动静脉畸形(AVM)仍存在争议。
介绍伽玛刀放射外科治疗脑动静脉畸形患者的长期随访数据。
1992 年至 2018 年,我们科室共有 516 例患者接受了脑动静脉畸形的放射外科治疗,其中 265 例单独接受了放射外科治疗,207 例接受了血管内-放射外科联合治疗。此外,还有 45 例患者接受了分期容积治疗。我们分析了两个时期的数据,1992 年至 2002 年为前现代时期,此后为现代时期。
在仅接受 GKRS 治疗的患者中,病灶闭塞的中位时间为 3.8 年。斯佩茨勒-庞塞(SP)分级是整个样本中闭塞时间的显著预测因素。联合治疗组的中位闭塞时间为 6.5 年。前现代时期的患者闭塞率明显高于现代时期的患者。总的来说,在首次 GKRS 后的观察期内,计算出的每年出血风险为 1.3%。永久性放射后并发症的发生率为 4.9%,但在治疗组和治疗时期之间没有差异。分期容积治疗的患者闭塞率明显较低,出血率较高。
GKRS 是 SP 分级 A 和 B 脑动静脉畸形的有效治疗选择。在接受血管内-放射外科联合治疗后,部分 SP 分级 C 动静脉畸形的结果与 SP 分级 B 病变的结果一致。血管内-放射外科联合治疗和单纯放射外科治疗都是治疗脑动静脉畸形的可靠方法。